跳至主要内容
临床试验/SLCTR/2018/019
SLCTR/2018/019招募中4 期

Synergistic Effects of delta-Tocotrienol, Resveratrol and Vitamin D Supplementation on Modulation of Biochemical Markers, Cytokines and miRNAs in patients of type 2 diabetes mellitus

Higher Education Commission (HEC) Pakistan0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Pakistani male and female patients 18-70 years of age.
  • 2. Patients of diabetes mellitus type 2 having HbA1C 7-12 %
  • 3. Taking oral hypoglycemic agent for at least one year.
  • 4. Duration of diabetes > 5 years

排除标准

  • 1. Acute illness
  • 2. Chronic illness including chronic liver disease, Seropositive for HIV, Hepatitis B or Hepatitis C
  • 3. Chronic kidney diseases
  • 4. Uncontrolled hypertension. SBP of >180 mmHg and DBP >110 mmHg
  • 5. Thyroid disorders (TSH <0.3 or >5.5 µIU/mL) or thyroid malignancy
  • 6. BMI more than 35 kg/m2
  • 7. Medical history/clinical evidence of familial hyperlipidemic disorder.
  • 8. Pregnant or lactating women
  • 9. Taking insulin, statins, anti-inflammatory drugs, vitamin E and vitamin D regularly or in the last 4 weeks
  • 10. Unable to give informed consent

研究者

发起方
Higher Education Commission (HEC) Pakistan

相似试验